Characteristics of the included studies (N=11)
| Study name and first author | Year of publication | Type of study | Study focus | Country of study implementation |
| HPTN 082 | ||||
| Celum36 | 2020 | Randomised controlled trial | PrEP uptake and continuation | South Africa & Zimbabwe |
| Velloza27 | 2021 | Qualitative study | ||
| Power Cohort Study | ||||
| Celum37 | 2022 | Pilot study | PrEP uptake and continuation | Kenya & South Africa |
| Roche38 | 2022 | Qualitative study | ||
| DREAMS | ||||
| Chabata39 | 2021 | Non-randomised evaluation | Uptake of PrEP and other HIV prevention strategies | Zimbabwe |
| Hensen40 | 2021 | Qualitative study | ||
| DREAMS | ||||
| Chimbindi41 | 2022 | Mixed-methods study | Uptake of PrEP and other HIV prevention strategies | South Africa |
| MPYA | ||||
| Haberer42 | 2022 | Cohort study | PrEP continuation | |
| Haberer43 | 2021 | Randomised controlled trial | Kenya | |
| 3Ps for Prevention Study | ||||
| Celum44 | 2020 | Randomised controlled trial | PrEP continuation | South Africa |
| Morton45 | 2020 | Mixed-method study | PrEP demand creation | |
.DREAMS, Determined Resilient, Empowered, AIDS-free, Mentored and Safe; HPTN, HIV Prevention Trials Network; MYPA, Monitoring Pre-Exposure Prophylaxis for Young Adult Women; POWER, The Prevention Options for Women Evaluation Research.